Oseltamivir Market By Product Type (Suspension, Capsule, and Others), By Application (Influenza A, Influenza B, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: Nov 2024
Report ID: 133435
Number of Pages:
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Market Snapshot
  - 1.3. Market Overview
  - 1.4. Segment Overview
  - 1.5. Regional Overview
  - 1.6. Competitive Landscape
  - 1.7. Taxonomy
- 2. Global Market Overview
  - 2.1. Global Market Insights and Industry Overview
  - 2.2. Market Dynamics
    2.2.1. Drivers
    2.2.2. Restraints
    2.2.3. Opportunities
    2.2.4. Key Oseltamivir Market Trends
  - 2.3. Regulatory Framework
  - 2.4. Opportunity Map Analysis
  - 2.5. Opportunity Orbits
  - 2.6. PESTLE Analysis
  - 2.7. PORTER’S Five Force Analysis
  - 2.8. Drivers & Restraints Impact Analysis
  - 2.9. Value Chain Analysis
    2.9.1. List of Raw Materials Suppliers
    2.9.2. List of Oseltamivir Manufacturers
    2.9.3. List of Dealer/Distributors
  - 2.10. Regional Market Share and BPS Analysis
  - 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Oseltamivir Market Analysis and Forecast, By Segment, 2019-2033
  - 3.1. Key Findings
  - 3.2. Global Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 3.3. Global Oseltamivir Market Attractiveness Analysis, By Product Type
    3.3.1. Suspension
    3.3.1.1. Insights
    3.3.1.2. Key Takeaways
    3.3.2. Capsules
    3.3.2.1. Insights
    3.3.2.2. Key Takeaways
    3.3.3. Others
    3.3.3.1. Insights
    3.3.3.2. Key Takeaways
  - 3.4. Global Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 3.5. Global Oseltamivir Market Attractiveness Analysis, By Application
    3.5.1. Influenza A
    3.5.1.1. Insights
    3.5.1.2. Key Takeaways
    3.5.2. Influenza B
    3.5.2.1. Insights
    3.5.2.2. Key Takeaways
    3.5.3. Others
    3.5.3.1. Insights
    3.5.3.2. Key Takeaways
- 4. Global Oseltamivir Market Analysis and Forecast, By Region, 2019-2033
  - 4.1. Key Findings
  - 4.2. Global Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
    4.2.1. North America
    4.2.1.1. Regional Insights
    4.2.2. Europe
    4.2.2.1. Regional Insights
    4.2.3. Asia Pacific
    4.2.3.1. Regional Insights
    4.2.4. Latin America
    4.2.4.1. Regional Insights
    4.2.5. Middle East & Africa
    4.2.5.1. Regional Insights
  - 4.3. Global Oseltamivir Market Attractiveness Analysis, By Region
- 5. North America Oseltamivir Market Analysis and Forecast, 2019-2033
  - 5.1. Key Findings
  - 5.2. North America Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 5.3. North America Oseltamivir Market Attractiveness Analysis, By Product Type
  - 5.4. North America Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 5.5. North America Oseltamivir Market Attractiveness Analysis, By Application
  - 5.6. North America Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 5.7. North America Oseltamivir Market Attractiveness Analysis, By Country
    5.7.1. The US
    5.7.2. Canada
- 6. Europe Oseltamivir Market Analysis and Forecast, 2019-2033
  - 6.1. Key Findings
  - 6.2. Europe Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 6.3. Europe Oseltamivir Market Attractiveness Analysis, By Product Type
  - 6.4. Europe Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 6.5. Europe Oseltamivir Market Attractiveness Analysis, By Application
  - 6.6. Europe Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 6.7. Europe Oseltamivir Market Attractiveness Analysis, By Country
    6.7.1. Germany
    6.7.2. The UK
    6.7.3. France
    6.7.4. Spain
    6.7.5. Italy
    6.7.6. Russia
    6.7.7. Netherland
    6.7.8. Rest of Europe
- 7. Asia Pacific Oseltamivir Market Analysis and Forecast, 2019-2033
  - 7.1. Key Findings
  - 7.2. Asia Pacific Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 7.3. Asia Pacific Oseltamivir Market Attractiveness Analysis, By Product Type
  - 7.4. Asia Pacific Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 7.5. Asia Pacific Oseltamivir Market Attractiveness Analysis, By Application
  - 7.6. Asia Pacific Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 7.7. Asia Pacific Oseltamivir Market Attractiveness Analysis, By Country
    7.7.1. China
    7.7.2. Japan
    7.7.3. South Korea
    7.7.4. India
    7.7.5. Australia
    7.7.6. New Zealand
    7.7.7. Singapore
    7.7.8. Thailand
    7.7.9. Vietnam
    7.7.10. Rest of Asia Pacific
- 8. Latin America Oseltamivir Market Analysis and Forecast, 2019-2033
  - 8.1. Key Findings
  - 8.2. Latin America Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 8.3. Latin America Oseltamivir Market Attractiveness Analysis, By Product Type
  - 8.4. Latin America Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 8.5. Latin America Oseltamivir Market Attractiveness Analysis, By Application
  - 8.6. Latin America Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 8.7. Latin America Oseltamivir Market Attractiveness Analysis, By Country
    8.7.1. Brazil
    8.7.2. Mexico
    8.7.3. Rest of Latin America
- 9. Middle East & Africa Oseltamivir Market Analysis and Forecast, 2019-2033
  - 9.1. Key Findings
  - 9.2. Middle East & Africa Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2019-2033
  - 9.3. Middle East & Africa Oseltamivir Market Attractiveness Analysis, By Product Type
  - 9.4. Middle East & Africa Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2019-2033
  - 9.5. Middle East & Africa Oseltamivir Market Attractiveness Analysis, By Application
  - 9.6. Middle East & Africa Oseltamivir Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
  - 9.7. Middle East & Africa Oseltamivir Market Attractiveness Analysis, By Country
    9.7.1. South Africa
    9.7.2. Saudi Arabia
    9.7.3. UAE
    9.7.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
  - 10.1. Market Competition Scenario Analysis, By Company
    10.1.1. Key Takeaways
  - 10.2. Overview of Major Market Players
  - 10.3. Competitor Landscape
  - 10.4. Strategic Mapping
  - 10.5. Company Life Cycle Analysis
  - 10.6. Company Market Share Analysis
  - 10.7. Company Profiles
    10.7.1. Zydus Cadila
    10.7.1.1. Company Details
    10.7.1.2. Business Overview
    10.7.1.3. Product Portfolio
    10.7.1.4. Financial Insights
    10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.1.6. SWOT Analysis
    10.7.1.7. Geographic Footprint
    10.7.2. NATCO Pharma Limited
    10.7.2.1. Company Details
    10.7.2.2. Business Overview
    10.7.2.3. Product Portfolio
    10.7.2.4. Financial Insights
    10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.2.6. SWOT Analysis
    10.7.2.7. Geographic Footprint
    10.7.3. Macleods Pharmaceuticals Ltd
    10.7.3.1. Company Details
    10.7.3.2. Business Overview
    10.7.3.3. Product Portfolio
    10.7.3.4. Financial Insights
    10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.3.6. SWOT Analysis
    10.7.3.7. Geographic Footprint
    10.7.4. Lupin
    10.7.4.1. Company Details
    10.7.4.2. Business Overview
    10.7.4.3. Product Portfolio
    10.7.4.4. Financial Insights
    10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.4.6. SWOT Analysis
    10.7.4.7. Geographic Footprint
    10.7.5. Hetero Healthcare Limited
    10.7.5.1. Company Details
    10.7.5.2. Business Overview
    10.7.5.3. Product Portfolio
    10.7.5.4. Financial Insights
    10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.5.6. SWOT Analysis
    10.7.5.7. Geographic Footprint
    10.7.6. F. Hoffmann-La Roche Ltd
    10.7.6.1. Company Details
    10.7.6.2. Business Overview
    10.7.6.3. Product Portfolio
    10.7.6.4. Financial Insights
    10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.6.6. SWOT Analysis
    10.7.6.7. Geographic Footprint
    10.7.7. Cipla Inc.
    10.7.7.1. Company Details
    10.7.7.2. Business Overview
    10.7.7.3. Product Portfolio
    10.7.7.4. Financial Insights
    10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.7.6. SWOT Analysis
    10.7.7.7. Geographic Footprint
    10.7.8. Amneal Pharmaceuticals LLC
    10.7.8.1. Company Details
    10.7.8.2. Business Overview
    10.7.8.3. Product Portfolio
    10.7.8.4. Financial Insights
    10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.8.6. SWOT Analysis
    10.7.8.7. Geographic Footprint
    10.7.9. Alembic Pharmaceuticals Limited
    10.7.9.1. Company Details
    10.7.9.2. Business Overview
    10.7.9.3. Product Portfolio
    10.7.9.4. Financial Insights
    10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
    10.7.9.6. SWOT Analysis
    10.7.9.7. Geographic Footprint
- 11. Methodology and Data Source
  - 11.1. Methodology/Research Approach
  - 11.2. Market Size Estimation
  - 11.3. Market Breakdown and Data Triangulation
  - 11.4. Data Source
  - 11.5. Secondary Sources
  - 11.6. Primary Sources
  - 11.7. Appendix
  - 11.8. Disclaimer
- List of Tables
  - Table 1. Global Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 2. Global Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 3. Global Oseltamivir Market Value (US$ Mn), By Region, 2019-2033
  - Table 4. North America Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 5. North America Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 6. North America Oseltamivir Market Value (US$ Mn), By Country, 2019-2033
  - Table 7. The US Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 8. The US Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 9. Canada Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 10. Canada Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 11. Europe Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 12. Europe Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 13. Europe Oseltamivir Market Value (US$ Mn), By Country, 2019-2033
  - Table 14. Germany Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 15. Germany Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 16. The UK Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 17. The UK Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 18. France Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 19. France Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 20. Spain Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 21. Spain Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 22. Italy Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 23. Italy Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 24. Russia Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 25. Russia Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 26. Netherland Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 27. Netherland Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 28. Rest of Europe Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 29. Rest of Europe Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 30. Asia Pacific Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 31. Asia Pacific Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 32. Asia Pacific Oseltamivir Market Value (US$ Mn), By Country, 2019-2033
  - Table 33. China Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 34. China Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 35. India Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 36. India Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 37. Japan Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 38. Japan Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 39. South Korea Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 40. South Korea Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 41. Australia Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 42. Australia Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 43. New Zealand Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 44. New Zealand Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 45. Singapore Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 46. Singapore Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 47. Thailand Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 48. Thailand Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 49. Vietnam Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 50. Vietnam Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 51. Rest of Asia Pacific Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 52. Rest of Asia Pacific Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 53. Latin America Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 54. Latin America Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 55. Latin America Oseltamivir Market Value (US$ Mn), By Country, 2019-2033
  - Table 56. Brazil Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 57. Brazil Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 58. Mexico Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 59. Mexico Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 60. Rest of Latin America Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 61. Rest of Latin America Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 62. Middle East & Africa Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 63. Middle East & Africa Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 64. Middle East & Africa Oseltamivir Market Value (US$ Mn), By Country, 2019-2033
  - Table 65. South Africa Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 66. South Africa Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 67. Saudi Arabia Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 68. Saudi Arabia Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 69. UAE Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 70. UAE Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
  - Table 71. Rest of Middle East & Africa Oseltamivir Market Value (US$ Mn), By Product Type, 2019-2033
  - Table 72. Rest of Middle East & Africa Oseltamivir Market Value (US$ Mn), By Application, 2019-2033
- List of Figures
  - Figure 1. Global Oseltamivir Market Snapshot: Market Value (US$ Mn), 2019-2033
  - Figure 2. Opportunity Map
  - Figure 3. Opportunity Orbit
  - Figure 4. Regional Market Share and BPS Analysis in Oseltamivir Market
  - Figure 5. Global Oseltamivir Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 6. Global Oseltamivir Market Attractiveness Analysis, By Product Type
  - Figure 7. Global Oseltamivir Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 8. Global Oseltamivir Market Attractiveness Analysis, By Application
  - Figure 9. Global Oseltamivir Market Analysis, By Region, 2019, 2023 and 2033
  - Figure 10. Global Oseltamivir Market Attractiveness Analysis, By Region
  - Figure 11. North America Oseltamivir Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 12. North America Oseltamivir Market Attractiveness Analysis, By Product Type
  - Figure 13. North America Oseltamivir Market (US$ Mn), by Suspension, 2019-2033
  - Figure 14. North America Oseltamivir Market (US$ Mn), by Capsules, 2019-2033
  - Figure 15. North America Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 16. North America Oseltamivir Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 17. North America Oseltamivir Market Attractiveness Analysis, By Application
  - Figure 18. North America Oseltamivir Market (US$ Mn), by Influenza A, 2019-2033
  - Figure 19. North America Oseltamivir Market (US$ Mn), by Influenza B, 2019-2033
  - Figure 20. North America Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 21. North America Oseltamivir Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 22. North America Oseltamivir Market Attractiveness Analysis, By Country
  - Figure 23. Europe Oseltamivir Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 24. Europe Oseltamivir Market Attractiveness Analysis, By Product Type
  - Figure 25. Europe Oseltamivir Market (US$ Mn), by Suspension, 2019-2033
  - Figure 26. Europe Oseltamivir Market (US$ Mn), by Capsules, 2019-2033
  - Figure 27. Europe Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 28. Europe Oseltamivir Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 29. Europe Oseltamivir Market Attractiveness Analysis, By Application
  - Figure 30. Europe Oseltamivir Market (US$ Mn), by Influenza A, 2019-2033
  - Figure 31. Europe Oseltamivir Market (US$ Mn), by Influenza B, 2019-2033
  - Figure 32. Europe Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 33. Europe Oseltamivir Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 34. Europe Oseltamivir Market Attractiveness Analysis, By Country
  - Figure 35. Asia Pacific Oseltamivir Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 36. Asia Pacific Oseltamivir Market Attractiveness Analysis, By Product Type
  - Figure 37. Asia Pacific Oseltamivir Market (US$ Mn), by Suspension, 2019-2033
  - Figure 38. Asia Pacific Oseltamivir Market (US$ Mn), by Capsules, 2019-2033
  - Figure 39. Asia Pacific Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 40. Asia Pacific Oseltamivir Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 41. Asia Pacific Oseltamivir Market Attractiveness Analysis, By Application
  - Figure 42. Asia Pacific Oseltamivir Market (US$ Mn), by Influenza A, 2019-2033
  - Figure 43. Asia Pacific Oseltamivir Market (US$ Mn), by Influenza B, 2019-2033
  - Figure 44. Asia Pacific Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 45. Asia Pacific Oseltamivir Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 46. Asia Pacific Oseltamivir Market Attractiveness Analysis, By Country
  - Figure 47. Latin America Oseltamivir Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 48. Latin America Oseltamivir Market Attractiveness Analysis, By Product Type
  - Figure 49. Latin America Oseltamivir Market (US$ Mn), by Suspension, 2019-2033
  - Figure 50. Latin America Oseltamivir Market (US$ Mn), by Capsules, 2019-2033
  - Figure 51. Latin America Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 52. Latin America Oseltamivir Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 53. Latin America Oseltamivir Market Attractiveness Analysis, By Application
  - Figure 54. Latin America Oseltamivir Market (US$ Mn), by Influenza A, 2019-2033
  - Figure 55. Latin America Oseltamivir Market (US$ Mn), by Influenza B, 2019-2033
  - Figure 56. Latin America Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 57. Latin America Oseltamivir Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 58. Latin America Oseltamivir Market Attractiveness Analysis, By Country
  - Figure 59. Middle East & Africa Oseltamivir Market Analysis, By Product Type, 2019, 2023 and 2033
  - Figure 60. Middle East & Africa Oseltamivir Market Attractiveness Analysis, By Product Type
  - Figure 61. Middle East & Africa Oseltamivir Market (US$ Mn), by Suspension, 2019-2033
  - Figure 62. Middle East & Africa Oseltamivir Market (US$ Mn), by Capsules, 2019-2033
  - Figure 63. Middle East & Africa Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 64. Middle East & Africa Oseltamivir Market Analysis, By Application, 2019, 2023 and 2033
  - Figure 65. Middle East & Africa Oseltamivir Market Attractiveness Analysis, By Application
  - Figure 66. Middle East & Africa Oseltamivir Market (US$ Mn), by Influenza A, 2019-2033
  - Figure 67. Middle East & Africa Oseltamivir Market (US$ Mn), by Influenza B, 2019-2033
  - Figure 68. Middle East & Africa Oseltamivir Market (US$ Mn), by Others, 2019-2033
  - Figure 69. Middle East & Africa Oseltamivir Market Analysis, By Country, 2019, 2023 and 2033
  - Figure 70. Middle East & Africa Oseltamivir Market Attractiveness Analysis, By Country
- Zydus Cadila
- NATCO Pharma Limited
- Macleods Pharmaceuticals Ltd
- Lupin Ltd Company Profile
- Hetero Healthcare Limited
- F. Hoffmann-La Roche Ltd
- Cipla Inc.
- Amneal Pharmaceuticals LLC
- Alembic Pharmaceuticals Limited
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)